Newsletter
Earnings
Interviews
Transcripts
×
Menu
Home
Earnings
Interviews
Transcripts
IPO
Tech
Regeneron Pharmaceuticals
Regeneron Full Year Revenue Totals $14.34 Billion
January 30, 2026
Top